Importance of the neutrophil-to-lymphocyte ratio in muscle-invasive and non-muscle invasive bladder tumors

被引:25
|
作者
Ceylan, Cavit [1 ]
Doluoglu, Omer G. [2 ]
Keles, Ibrahim [3 ]
Gazel, Eymen [1 ]
Temucin, Tulay [4 ]
Odabas, Oner [1 ]
Karalar, Mustafa [3 ]
机构
[1] Yuksek Ihtisas Training & Res Hosp, Dept Urol, Ankara, Turkey
[2] Ankara Numune Training & Res Hosp, Urol Clin, Ankara, Turkey
[3] Afyon Kocatepe Univ, Med Fac, Urol Clin, Afyon, Turkey
[4] Yuksek Ihtisas Training & Res Hosp, Dept Pathol, Clin Turkiye, Ankara, Turkey
关键词
Neutrophil-to-lymphocyte ratio; Transurethral resection; Urinary bladder neoplasm;
D O I
10.5301/uro.5000031
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: To research the importance of the neutrophil-to-lymphocyte ratio (NLR) in muscleinvasive bladder cancers (MIBC) and non-muscle invasive bladder cancer (NMIBC). Methods: Data of 198 patients who underwent TUR-TM in our clinic were retrospectively evaluated. Patients were divided into two groups: group-I (MIBC) and group-II (NMIBC). The neutrophil and lymphocyte counts, NLR, hemoglobin and hematocrit values, tumor numbers, sizes and degrees of patients were recorded. Within the inter-group comparison, Mann-Whitney U test was used for the values stated with measuring, whereas a Chi-square test was used for the values stated with counting. The cut-off value for the NLR was determined with ROC curve. Results: The NLR values of group-I and group-II were found as 4.14 +/- 2.76 and 3.36 +/- 2.88, respectively (p = 0.03). Whether the NLR carries a differential property was evaluated with ROC curve. The cut-off value was estimated as 3.96 according to the Youden index. With this value, sensitivity was found as 50%, specificity was 22.8% and AUC was 0.615 (p = 0.03). Discussion: According to the data in this study, it can be said that Ta-T1 tumors are likely to be invasive by 50% if the NLR value is greater than 3.96.
引用
收藏
页码:120 / 124
页数:5
相关论文
共 50 条
  • [21] Intravesical Therapies in Non-muscle Invasive Bladder Tumors
    Geyik, Serdar
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2019, 18 (01): : 24 - 29
  • [22] Intravesical therapy of non-muscle invasive bladder tumors
    vom Dorp, F.
    Tschirdewahn, S.
    Luemmen, G.
    UROLOGE, 2012, 51 (02): : 257 - 262
  • [23] Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study
    Favilla, Vincenzo
    Castelli, Tommaso
    Urzi, Daniele
    Reale, Giulio
    Privitera, Salvatore
    Salici, Antonio
    Russo, Giorgio Ivan
    Cimino, Sebastiano
    Morgia, Giuseppe
    INTERNATIONAL BRAZ J UROL, 2016, 42 (04): : 685 - 693
  • [24] Prognostic value of preoperative neutrophil-to-lymphocyte ratio in histological variants of non-muscle-invasive bladder cancer
    Li, Deng-Xiong
    Wang, Xiao-Ming
    Tang, Yin
    Yang, Yu-Bo
    Feng, De-Chao
    Li, Ao
    Zhang, Fa-Cai
    Bai, Yun-Jin
    Han, Ping
    INVESTIGATIVE AND CLINICAL UROLOGY, 2021, 62 (06) : 641 - 649
  • [25] Can the neutrophil-to-lymphocyte ratio be used to predict recurrence and progression of non-muscle-invasive bladder cancer?
    Albayrak, Sebahattin
    Zengin, Kursad
    Tanik, Serhat
    Atar, Muhittin
    Unal, Serhat Haluk
    Imamoglu, M. Abdurrahim
    Gurdal, Mesut
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2016, 32 (06): : 327 - 333
  • [26] Preoperative neutrophil-to-lymphocyte ratio (NLR) value as a predictor of recurrence of non-muscle-invasive bladder cancer
    Ivanic, Davor
    Dug, Haris
    Jagodic, Samed
    Delibegovic, Samir
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2025, 57 (04) : 1143 - 1149
  • [27] DOES THE NEUTROPHIL-TO-LYMPHOCYTE RATIO PLAY A PROGNOSTIC ROLE IN UNSELECTED NON-MUSCLE-INVASIVE BLADDER CANCER?
    Serretta, Vincenzo
    Ventura, Giorgio
    Bevilacqua, Giulio
    Billeci, Sandro
    Gesolfo, Cristina Scalici
    Vella, Marco
    Sanfilippo, Chiara
    ANTICANCER RESEARCH, 2018, 38 (04) : 2499 - 2500
  • [28] PREOPERATIVE NEUTROPHIL-TO-LYMPHOCYTE RATIO AND SMOKING HISTORY ARE INDEPENDENTLY ASSOCIATED WITH BCG RELAPSING TUMOR RECURRENCE IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS
    Ogihara, Koichiro
    Kikuchi, Eiji
    Yanai, Yoshinori
    Takamatsu, Kimiharu
    Shirotake, Suguru
    Matsumoto, Kazuhiro
    Oyama, Masafumi
    Nagata, Hirohiko
    Miyajima, Akira
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2017, 197 (04): : E904 - E905
  • [29] Correlation of Immune Cells and Cytokines in the Tumor Microenvironment with Elevated Neutrophil-To-Lymphocyte Ratio in Blood: An Analysis of Muscle-Invasive Bladder Cancer
    Morizawa, Yosuke
    Miyake, Makito
    Shimada, Keiji
    Hori, Shunta
    Tatsumi, Yoshihiro
    Nakai, Yasushi
    Onishi, Sayuri
    Tanaka, Nobumichi
    Konishi, Noboru
    Fujimoto, Kiyohide
    CANCER INVESTIGATION, 2018, 36 (07) : 395 - 405
  • [30] NEUTROPHIL TO LYMPHOCYTE RATIO, A NEW PROGNOSTIC FACTOR IN NON MUSCLE INVASIVE BLADDER CANCER
    Favilla, Vincenzo
    Castelli, Tommaso
    Urzi, Daniele
    Cimino, Sebastiano
    Privitera, Salvatore
    Fragala, Eugenia
    Russo, Giorgio Ivan
    Morgia, Giuseppe
    JOURNAL OF UROLOGY, 2015, 193 (04): : E299 - E300